Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years

British Medical Journal

Volumn 312, Issue 7036, 1996, Pages 935-939

  Weintraub, Moshe S ^a   Grosskopf, Itamar ^a   Rassin, Toby ^a   Miller, Hylton ^a   Charach, Gideon ^a   Rotmensch, Heschi H ^a   Liron, Meir ^a   Rubinstein, Ardon ^a   Iaina, Adrian ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; RETINOL PALMITATE; DIAGNOSTIC AGENT; LIPID; LIPOPROTEIN; RETINOL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CHEMICAL LABELING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICS; BLOOD; FAT INTAKE; METABOLISM; MIDDLE AGED;

ADULT; AGED; CASE-CONTROL STUDIES; CHYLOMICRONS; CORONARY DISEASE; DIETARY FATS; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIGLYCERIDES; VITAMIN A;

EID: 0029930125     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7036.935     Document Type: Article

References (44)

1. Lipid Research Clinics. Coronary primary prevention trial results. II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-74.
2. Gordon T, Castelli WP, Hjortland MD, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 1977;62:707-14.
3. Miller NE, Hammet F, Saltissi S. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. BMJ 1981;282:1741-4.
4. Lippel K, Tyroler H, Eder H. Meeting summary: relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis 1981;1:406-17.
5. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-85.
6. Morganroth J, Levy RI, Fedrickson DS. The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Intern Med 1975;82:158-64.
7. Nestel PJ, Fidge NH, Tan NH. Increased lipoprotein remnant formation in chronic renal failure. N Engl J Med 1982;307:327-33.
8. Kane JP, Chen GC, Hamilton RL, Hardman DA, Malloy MJ, Havel RJ. Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis 1983;3:47-56.
9. Thompson KH, Zilversmit DB. Plasma very low density lipoprotein (VLDL) in cholesterol-fed rabbits: chylomicron remnants or liver lipoprotein? J Nutr 1983;113:2002-9.
10. Floren CH, Albers JJ, Bierman EL. Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochim Biophys Acta 1981;663:336-49.
11. Blanchett-Mackie EJ, Scow RO. Sites of lipoprotein lipase activity in adipose tissue perfused with chylomicrons. Electron microscopic, cytochemical study. J Cell Biol 1971;51:1-25.
12. Stender S, Zilversmit DB. Arterial influx of esterified cholesterol from two plasma lipoprotein fractions and its hydrolysis in vivo in hypercholesterolemic rabbits. Atherosclerosis 1981;39:97-109.
13. Stender S, Zilversmit DB. Comparison of cholesterol ester transfer from chylomicrons and other plasma lipoproteins to aorta intima-media of cholesterol-fed rabbit. Arteriosclerosis 1982;2:493-9.
14. Goldstein JL, Ho YK, Brown MS, Innerarity TL, Mahley RW. Cholesterol ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta very low density lipoproteins. J Biol Chem 1980;255:1839-48.
15. Gianturco SH, Lin AH, Hwang SL, Young J, Brown SA, Via DP. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins. J Clin Invest 1988;82:1633-43.
16. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats of W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest 1988;82;1884-93.
17. Demacker PNM, Reijnen IGM, Katan MB, Stuyt PMJ, Stalenhoef AFH. Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids. Eur J Clin Invest 1991;21:197-203.
18. Weintraub MS, Rosen Y, Otto R, Eisenberg S, Breslow JL. Physical exercise conditioning in the absence of weight loss reduces fasting and postprandial triglyceride-rich lipoprotein levels. Circulation 1989;79:1007-14.
19. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-7.
20. Weintraub MS, Ringel Y, Rassin T, Arad J, Bodner G, Liron M. Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis. Journal of Gerontology 1992;47:B209-13.
21. Groot PHE, van Stiphout WAHJ, Krauss XH, Jansen H, van Tol A, van Ramshaorst E, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-62.
22. Hazard WR, Bierman EL. Delayed clearance of chylomicron remnants following vitamin A-containing oral fat load in broad-B disease (type III hyperlipoproteinemia). Metabolism 1976;25:777-801.
23. Wilson DE, Chan I, Ball M. Plasma lipoprotein retinoids after vitamin A feeding in normal man. Minimal appearance of retinyl esters among low density lipoproteins. Metabolism 1983;32:514-7.
24. Berr F, Kem F Jr. Plasma clearance of chylomicrons labelled with retinyl palmitate in healthy human subjects. J Lipid Res 1984;25:805-12.
25. Wilson DE, Chan I, Buchi KN, Horton SC. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia. Metabolism 1985;34:551-8.
26. Berr F, Eckel RH, Kern F. Plasma decay of chylomicron remnants is not affected by heparin-stimulated plasma lipolytic activity in normal fasting man. J Lipid Res 1985;26:852-9.
27. Berr F, Eckel RH, Kern F. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. J Lipid Res 1986;27:645-51.
28. Conner JA, Coates PM, Lee NA, Cryer DD, Ragni MC, Faulkner A, et al. Kinetics of chylomicron remnant clearance in normal and hypertipoproteinemic subjects. J Lipid Res 1987;28:195-206.
29. Weintraub MS, Eisenberg S, Breslow JL. Different patterns of postprandial metabolism in normals and type IIa, type III and type IV hyperlipoproteinemics: effects of treatment with cholestyramine and gemfibrozil. J Clin Invest 1987;79:1110-9.
30. Grundy SM, Mok HYI. Chylomicron clearance in normal and hyperlipidemic man. Metabolism 1976;25:1225-39.
31. Dale VP, Hamlin JI. Particulate fat in lymph and blood. Physiol Rev 1962;42:674-701.
32. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of serum lipoproteins. In: Nelson GS, ed. Blood lipids and lipoproteins: quantitation, composition and metabolism. New York: Wiley Interscience, 1972:181-274.
33. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
34. Korn ED. Clearing factor, a heparin activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem 1955;215:1-14.
35. Schoefe GI, French JE. Vascular permeability to particulate fate: morphological observation on levels of lactating mammary gland and of lung. Proceedings of the Royal Society of London. Series B: Biological Sciences 1968;169:153-65.
36. Redgrave TG. Formation of cholesterol ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest 1970;49:465-71.
37. Goodman DS. The metabolism of chylomicron cholesterol ester in the rat. J Clin Invest 1962;41:1886-96.
38. Hui DY, Innerarity TL, Mahley RW. Lipoprotein binding to canine hepatic membranes: metabolically distinct apo-E and apo-B,E receptors. J Biol Chem 1981;256:5646-55.
39. Hui DY, Brecht WJ, Hall EA, Friedman G, Innerarity TL, Mahley RW. Isolation and characterization of the apolipoprotein E receptor from canine and human liver. J Biol Chem 1986;261:4256-67.
40. Krainski SD, Cohn JS, Russel RM, Schaefer EJ. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism 1990;39:357-65.
41. Karpe F, Bell M, Bjorkegren J, Hamsten A. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apoliporotein B-48 and B-100. Arterioscler Thromb Vasc Biol 1995;15:199-207.
42. Hollander D. Intestinal absorption of vitamins A, E, D, and K. J Lab Clin Med 1981;97:449-62.
43. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr. Inverse relationship between blood levels of high density lipoprotein subtractions 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 1983;80:1449-53.
44. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984;25:1017-58.